Communication Issues in Patient and Provider Discussions of Immunotherapy

Active:	Yes
Cancer Type:	Solid Tumor	NCT ID:	NCT05873608
Trial Phases:		Protocol IDs:	WINSHIP3293-16 (primary) NCI-2020-00828 IRB00091198
Eligibility:	0 Years and older, Male and Female	Study Type:	Health services research
Study Sponsor:	Emory University Hospital/Winship Cancer Institute
NCI Full Details:	http://clinicaltrials.gov/show/NCT05873608

Summary

This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what they understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.

Objectives

PRIMARY OBJECTIVES:
I. To identify misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources and assess if these misestimations persist post-provider conversation about immunotherapy.
II. To qualitatively describe patient reported misunderstandings and to assess patient understanding of technical terms and metaphors used in the immunotherapy conversation.
III. To identify provider and patient preferences for information to be communicated about immunotherapy.
IV. Develop videos that describe immunotherapy and test their efficacy in improving understanding using pre and post methodology.

OUTLINE:
Patients and their providers undergo observation during a conversation about immunotherapy. They then participate in an interview over 20 minutes. Patients may also watch educational videos about immunotherapy.

Treatment Sites in Georgia

Atlanta VA Medical Center
1670 Clairmont Road
Decatur, GA 30033
404-728-7680
www.atlanta.va.gov

Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
404-778-5180
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.